deltatrials
Completed PHASE3 INTERVENTIONAL 3-arm NCT03782103

In-vivo Efficacy of Patient Preoperative Prep, ZuraPrep (ZP) (ZP)

Clinical Evaluation of the Antimicrobial Effectiveness of Topically Applied ZuraPrep

Sponsor: Zurex Pharma, Inc.

Conditions Surgical Skin Preparation
Interventions ChloraPrep ZuraPrep Clear Solution ZuraPrep Vehicle
Updated 14 times since 2019 Last updated: Feb 6, 2023 Started: Jan 25, 2019 Primary completion: May 12, 2019 Completion: Sep 26, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Surgical Skin Preparation and is currently completed. Zurex Pharma, Inc. leads this study, which shows 14 recorded versions since 2019 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2019 – ~Mar 2019 · 59 days · monthly snapshot~Mar 2019 – ~Aug 2019 · 5 months · monthly snapshot~Aug 2019 – ~Dec 2019 · 4 months · monthly snapshot~Dec 2019 – ~Aug 2020 · 8 months · monthly snapshot~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Apr 2022 · 7 months · monthly snapshot~Apr 2022 – ~Sep 2022 · 5 months · monthly snapshot~Sep 2022 – ~Dec 2022 · 3 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Mar 2023 · 59 days · monthly snapshot~Mar 2023 – ~Jul 2024 · 16 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 23 months · monthly snapshot

Change History

14 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Mar 2023 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jan 2023 — Mar 2023 [monthly]

    Completed PHASE3

  5. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE3

▶ Show 9 earlier versions

  1. Sep 2022 — Dec 2022 [monthly]

    Completed PHASE3

  2. Apr 2022 — Sep 2022 [monthly]

    Completed PHASE3

  3. Sep 2021 — Apr 2022 [monthly]

    Completed PHASE3

  4. Jan 2021 — Sep 2021 [monthly]

    Completed PHASE3

  5. Aug 2020 — Jan 2021 [monthly]

    Completed PHASE3

  6. Dec 2019 — Aug 2020 [monthly]

    Completed PHASE3

    Status: Active Not Recruiting → Completed

  7. Aug 2019 — Dec 2019 [monthly]

    Active Not Recruiting PHASE3

    Status: Recruiting → Active Not Recruiting

  8. Mar 2019 — Aug 2019 [monthly]

    Recruiting PHASE3

    Status: Not Yet Recruiting → Recruiting

  9. Jan 2019 — Mar 2019 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Zurex Pharma, Inc.
Data source: Zurex Pharma, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations